By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Lantibio Inc. 

100 Europa Drive, Suite 421

Chapel Hill  North Carolina  27517  U.S.A.
Phone: 919-960-0217 Fax: 919-929-3447



Company News
Lantibio Inc. and TRB Chemedica Announce Licensing Agreement with Alcon Laboratories, Inc. (ACL) for US Development and Marketing of Dry Eye Drug 11/6/2007 7:37:18 AM
AOP Orphan Pharmaceuticals AG and Lantibio Inc. Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy 3/7/2007 10:16:31 AM
Lantibio Inc. And TRB Chemedica Announce Special Protocol Assessment-Endorsed Phase III Trial Initiation Of VISMED(R) For Dry Eye Syndrome 1/17/2007 8:50:02 AM
Lantibio Inc. And TRB Chemedica Announce Agreement For US Development And Marketing Of VISMED(R) 1/12/2006 11:06:24 AM
Lantibio Inc. Announces The Initiation Of Clinical Trials In Dry Eye Syndrome And The Company's Formation Of A Scientific Advisory Board10/19/2005 5:13:01 PM
AOP Orphan Pharmaceuticals And Lantibio, Inc. Announce A Licensing And Commercialization Agreement For Moli1901 In Cystic Fibrosis 10/19/2005 5:11:32 PM
Lantibio Inc. And Apotex Fermentation Inc. Announce A Development, Supply And Royalty Agreement For Lantibio's Lead Compound10/19/2005 5:09:09 PM